Phase I trial of temozolomide using an extended continuous oral schedule.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (9)
Analytical Methods Validation: Bioavailability, Bioequivalence, and Pharmacokinetic Studies
1992 • 1,134 citations
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
1992 • 483 citations
NMR and Molecular Modeling Investigation of the Mechanism of Activation of the Antitumor Drug Temozolomide and Its Interaction with DNA
1994 • 417 citations
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma.
1995 • 290 citations
Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
1997 • 221 citations
The charing cross hospital experience with temozolomide in patients with gliomas
1996 • 157 citations
Potentiation of temozolomide and BCNU cytotoxicity by O6-benzylguanine: a comparative study in vitro
1996 • 98 citations
A randomized study of CCNU with and without benznidazole in the treatment of recurrent grades 3 and 4 astrocytoma
1989 • 24 citations
Quality of pharmacokinetic research in oncology
1995 • 3 citations
Cited By (0)
No citing papers found in database